Produced by Beijing Kexing Biological Products Co., Ltd., it is the first vaccine enterprise listed in the United States in China, holding Beijing Kexing Biological Products Co., Ltd. Biotechnology? Limited) 7 1.6% of the shares. Beijing Kexing Holding Company also has a wholly-owned subsidiary in Tangshan, Hebei Province-Tangshan Yi 'an Bioengineering Co., Ltd., which is dedicated to the research and development of veterinary vaccines.
On June 4, 2009, 165438+ Beijing Kexing Holdings Co., Ltd. announced that it had successfully switched to the Nasdaq global market. It is expected that 165438+ 10 will be officially listed and traded on the Nasdaq Stock Exchange with the trading code of SVA. Previously, Beijing Kexing Holding Company was listed on the American Stock Exchange (AMEX).